newsfilter
← Latest News
GlobeNewswire·

VectivBio Announces Results of Extraordinary General Meeting

BASEL, Switzerland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare